| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8652292 | Annales de Cardiologie et d'Angéiologie | 2017 | 7 Pages |
Abstract
Coronary thrombosis remains the leading cause for cardiovascular death in France. Great advances have been made in the knowledge of the basic mechanism involved in coronary thrombogenesis and in antithrombotic treatments. They have led to substantial survival benefit after myocardial infarction and enabled development of tailored therapeutic strategies, especially for high-risk patients. Direct oral anticoagulants have now entered the game for secondary prevention after coronary thrombosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
M. Zeitouni, J. Silvain, M. Kerneis, P. Guedeney, P. Overtchouk, O. Barthelemy, M. Hauguel-Moreau, G. Montalescot, J.-P. Collet,